Abstracts tagged "Juvenile idiopathic arthritis (JIA) and temporomandibular joint"

Abstract Number: 980 • 2018 ACR/ARHP Annual Meeting
Long-Term Outcome of Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis:Results of 18-Year Follow-up in the Population-Based Nordic JIA Cohort
Mia Glerup¹, Peter Stoustrup², Louise Hauge Matzen³, Veronika Rypdal^4,5, Ellen Nordal^5,6, Paula Frid^5,7, Ellen Dalen Arnstad^8,9, Marite Rygg^10,11, Olafur Thorarensen¹², Maria Ekelund^13,14, Lillemor Berntson¹⁵, Anders Fasth¹⁶, Håkan Nilsson¹⁷, Suvi Peltoniemi¹⁸, Kristiina Aalto¹⁸, Sirpa Arte¹⁹, Peter Toftedal²⁰, Susan Nielsen²⁰, Sven Kreiborg²¹, Troels Herlin²² and Thomas Klit Pedersen^23,24, ¹Department of Pediatrics, Dept. of Pediatrics, Aarhus University Hospital, Denmark, Aarhus, Denmark, ²Section of Orthodontics, Section of Orthodontics, Aarhus University, Denmark, Aarhus, Denmark, ³Department of Oral Radiology, Dept. of Oral Radiology, Aarhus University, Denmark, Aarhus, Denmark, ⁴Dept. of Pediatrics, University Hospital of North Norway, Tromsø, Norway, ⁵Department of Clinical Medicine, Dept. of Clin. Med, UIT The Arctic University of Norway, Tromsø, Norway, ⁶Departments of Pediatrics, Dept. of Pediatrics, University Hospital of North Norway, Tromsø, Norway, ⁷Division of Oral and Maxillofacial Surgery, ENT-Dept. and Division of Oral and Maxillofacial Surgery, University Hospital North Norway and Public Dental Service Competence Centre of North Norway, Tromsø, Norway, ⁸Dep. Clin. and Mol. Med, Dept. Clin. and Mol. Med., NTNU, Norway, Trondheim, Norway, ⁹Department of Pediatrics, Dept. of Pediatrics, Levanger Hospital, Nord-Trøndelag, Norway, Trondheim, Denmark, ¹⁰Department of Pediatrics, Dept. of Pediatrics, St. Olavs Hospital, Norway, Trondheim, Norway, ¹¹Dep. Clin. and Mol. Med., Dept. Clin. and Mol. Med., NTNU, Norway, Trondheim, Norway, ¹²Dep. of oral and Craniomaxillofacial surgery, Dept. of oral and Craniomaxillofacial surgery, St. Olavs Hospital, Norway, NTNU, Trondheim, Norway, ¹³Department of Pediatrics, Dept. of Pediatrics, Ryhov County Hospital, Jonkoping, Sweden, Jonkoping, Sweden, ¹⁴Uppsala University, Uppsala, Sweden, Jonkobing, Sweden, ¹⁵Uppsala University, Uppsala, Sweden, Uppsala, Sweden, ¹⁶Sahlgrenska Academy, University of Gothenburg, Sweden, Gothenburg, Sweden, ¹⁷Department of Oral and Maxillofacial Surgery, Dept. of Oral and Maxillofacial Surgery, The Institute for Postgraduate Dental Education, Jönköping, Sweden, Jonkoping, Sweden, ¹⁸Hospital for Children and Adolescents, University of Helsinki, Finland, Helsinki, Finland, ¹⁹Dept. of Oral and Maxillofacial Diseases, University of Helsinki, Finland, Helsinki, Finland, ²⁰Department of Pediatrics, Dept. of Pediatrics, Copenhagen University Hospital, Denmark, Copenhagen, Denmark, ²¹Dept. of Paediatric Dentistry and Clinical Genetics, University of Copenhagen, Denmark, Copenhagen, Denmark, ²²Dept. of Pediatrics, Aarhus University Hospital, Aarhus N, Denmark, ²³Dept. of Oral and Maxillofacial Surgery, Aarhus University Hospital, Aarhus, Denmark, ²⁴Section of Orthodontics, Aarhus University, Denmark, Aarhus, Denmark
Background/Purpose: Involvement of the temporomandibular joint (TMJ) is a common finding in patients with juvenile idiopathic arthritis (JIA), but the long-term outcome in a non-selected…
Abstract Number: 61 • 2017 Pediatric Rheumatology Symposium
Which Juvenile Idiopathic Arthritis patient is more likely to have Temporomandibular Joint involvement?
shelly abramowicz¹, joshua levy², Curtis Travers³, Sampath Prahalad⁴ and Sheila Angeles-Han⁵, ¹Surgery, Emory University/Children's Healthcare of Atlanta, atlanta, GA, ²Surgery, Emory University, atlanta, GA, ³Pediatrics, Emory University School of Medicine, Atlanta, GA, ⁴Pediatrics, Emory Children's Center, Atlanta, GA, ⁵Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH
Background/Purpose: Juvenile Idiopathic Arthritis (JIA) affects approximately 300,000 children in the United States. Temporomandibular joint (TMJ) involvement in children with JIA can lead to decreased…
Abstract Number: 2017 • 2012 ACR/ARHP Annual Meeting
Orthopaedic Treatment of Temporomandibular Joint (TMJ) Damage in Adolescents with Juvenile Idiopathic Arthritis (JIA): Longitudinal Evaluation
Fernanda Falcini¹, Daniela Melchiorre², Giulia Carnesecchi³, Federico Bertini⁴, Katia Biondi⁵, Mario Bosco⁵ and Marco Matucci-Cerinic⁶, ¹Department of Biomedicine, Division of Rheumatology AOUC, Excellence Centre for Research, Florence, Italy, ²Department of Biomedicine, Division of Rheumatology, Department of Internal Medicine, Rheumatology Section, University of Florence, Florence, Italy, ³Department of Biomedicine, Division of Rheumatology, University of Florence, Florence, Italy, ⁴Department of Internal Medicine, Rheumatology Section, University of Florence, Florence, Italy, ⁵Department of Odontostomatologic Sciences, University of Pavia, Pavia, Italy, ⁶Department of Biomedicine & Division of Rheumatology AOUC, University of Florence, Florence, Italy
Background/Purpose: TMJ involvement has been reported in all subsets of JIA. The prevalence of radiographic changes of TMJs varies from 30% to 65%, and 50-80%…
Abstract Number: 1677 • 2012 ACR/ARHP Annual Meeting
Safety and Efficacy of Intra-Articular Infliximab Therapy for Treatment Resistant Temporomandibular Joint Arthritis in Children
Matthew L. Stoll¹, Anthony B. Morlandt², Suwat Teerawattanapong², Daniel Young³, Peter D. Waite⁴ and Randy Q. Cron¹, ¹Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²Department of Oral and Maxillofacial Surgery, University of Alabama at Birmingham, Birmingham, AL, ³Radiology, University of Alabama at Birmingham, Birmingham, AL, ⁴Oral and Maxillofacial Surgery, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Temporomandibular joint (TMJ) arthritis occurs in as much as 80% of children with juvenile idiopathic arthritis (JIA) and can result in substantial facial deformity.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].